Viewing Study NCT00185783



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00185783
Status: COMPLETED
Last Update Posted: 2011-04-11
First Post: 2005-09-12

Brief Title: Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis
Sponsor: Stanford University
Organization: Stanford University

Study Overview

Official Title: Pilot Study of White Blood Cell Gene Expression in Critically Ill Patients With Severe Sepsis and Relative Adrenal Insufficiency After Hydrocortisone Administration
Status: COMPLETED
Status Verified Date: 2011-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this pilot study is to 1 examine the changes in gene expression in patients who suffer from severe sepsis and whose shock inadequate oxygen delivery to vital organs state does not respond to fluid and vasopressor administration 2 to show that our sampling method of isolating RNA provides reliable and consistent data 3 provide a basis for future gene expression studies in critically ill patients
Detailed Description: Severe sepsis is characterized by inadequate perfusion of vital organs due to infection More than 750000 cases of severe sepsis occur each year in the United States Mortality among patients with severe sepsis ranges from 7 to 50 Initiation of antibiotic therapy within the first hour of diagnosis as well as fluid resuscitation and hemodynamic stabilization are primary goals of therapy

Steroid administration has been shown to improve outcome in the subset of severe sepsis patients suffering from relative adrenal insufficiency Although initial studies using high dose short course steroid therapy did not demonstrate efficacy more recent studies of low dose longer duration hydrocortisone administration demonstrated a significant reduction in mortality at 28 days The mechanism by which steroid administration affords protection is unclear We hypothesize that steroid administration changes white blood cell gene and protein expression in severe sepsis patients from an immuno-inflammatory profile to a pattern consistent with healing

Our first specific aim is to obtain plasma and total cellular RNA from leukocytes in the blood of ten patients admitted to Stanford Medical Center with the diagnosis of severe sepsis and adrenal insufficiency Significant and distinct variations in whole blood leukocyte gene expression patterns occur depending upon the method of RNA isolation We will attempt to demonstrate that our sampling method provides reliable and consistent data

Our second specific aim is to begin an analysis of gene expression patterns in white blood cells before and after steroid administration in patients suffering from severe sepsis with relative adrenal insufficiency We will use a protocol for assessment of gene expression that was developed by members of our research team

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Other Grant OTHER_GRANT Stanford University Department of Anesthesia None
Stanford IRB Number 4593 None None None